28
Views
19
CrossRef citations to date
0
Altmetric
Letters

Re: Controlled Use of Asbestos

Pages 99-103 | Published online: 19 Jul 2013

References

  • Castleman BI. “Controlled use” of asbestos. Int J Occupl Environ Health. 2003; 9: 294–8.
  • Ilgren E, Chatfield E. Coalinga fibre: a short, amphibole-free chrysotile. Part 3: Lack of biopersistence. Indoor Built Environment. 1998; 7: 98–109.
  • Pinkerton K. Lung Reaction to Inhala-tion of Three Types of Chrysotile Asbestos during the Lifespan of the Fis-cher 344 Rat. PhD thesis, Duke Univer-sity, Durham, NC, 1982.
  • Ilgren E, Chatfield E. Coalinga fibre: a short, amphibole-free chrysotile. Part 2: Evidence for lack of tumourigenic activity. Indoor Built Environment. 1998; 7: 98–109.
  • Conwed Corporation v. Union Carbide Corporation, Civil Action No. 5-92-88. Depo-sition of Edward Ilgren. August 13, 1998.
  • Rhodes HB, Ingalls BL. Comparrison of Airborne Asbestos Concentrations-Canadian and California Asbestos Based Ceiling Texture Sprays. Union Carbide Corporation Metals Division, New York, June 24, 1975.
  • Rhodes HB, Myers JL, et al. Informal Report 2196-64: The Occurrence of Ultra-Fine Fibers in “Calidria” RG-244 Asbestos Summary and Conclusions. August 24, 1978.
  • Ingalls BL, Kronkhyte RJ,et al. Internal Correspondence: Asbestos Dust Control Results of NIOSH Air Monitoring Survey of King City Bagging Room Operations. April 11, 1983.
  • Dodson RF, Atkinson MAL, Levin JL. Asbestos fiber length as related to potential pathogenicity: a critical review. Am J Ind Med. 2003; 44: 291–7.
  • Mellon Institute Special Report. The Fibrotic Potential of Asbestos Products via Intraperitoneal Injection in Guinea Pigs, Rats and Rabbits and by the Intra-tracheal Route in the Rat. Confidential Report 29-55, July 8, 1966.
  • Dernehl CU to TJ Hall. Internal memo, Re: “Asbestos as a Health Hazard in the United Kingdom,” June 7, 1967.
  • Mellon Institute Special Report 34-70. Calidria Asbestos-Resin Grade RG 244 Tracheal Insufflation of Rat Lungs with Interpretation of Pathology after 30, 60, 90, and 180 Days. Confidential Report 34-70, September 3, 1971.
  • Rhodes HB to DL Haywood. Reporting of “Health and Safety Studies to EPA” under TSCA Section 8(d) (4.3.12.2.2). November 29, 1982.
  • Ilgren E, Chatfield E. Coalinga fibre: a short, amphibole-free chrysotile. Part 1: Evidence for a lack of fibrogenic activity. Indoor Built Environment. 1997; 6: 264–109.
  • O'Neil J, Pinkerton K, Crapo C. Lung Volume Changes in Rats Exposed to Chrysotile Asbestos (abstract). Am Rev Resp Dis 1981; 123: 146.
  • Suzuki Y, Kohyama N., Malignant mesothelioma induced by asbestos and zeolite in the moue peritoneal cavity. Environ Res. 1984; 35: 277–92.
  • Suzuki Y. Carcinogenic and fibrogenic effects of zeolites: preliminary observa-tions. Environ Res. 1982; 27: 433–45.
  • Rittinghausen S, Ernst H, Muhle H, Mohr U. Atypical malignant mesothe-liornas with osseous and cartilaginous differentialtion after intraperitoneal injection of various types of mineral fibres on Rats. Exp Toxicol Pathol. 1992; 44: 55–58.
  • Maltoni C, Minardi F.Recent results of carcinogenicity bioassays of fibres and other particulate materials. IARC Sci Publ. 1989; 90: 46–53.
  • Maltoni C, Minardi F, Morisi L. The rel-evance of the experimental approach in the assessment of the oncogenic risks from fibrous and non-fibrous par-ticles. Med Lay. 1982; 4: 394–407.
  • Langer AM, et al. Variation of proper-ties of chrysotile asbestos subjected to milling. Jf Toxicol Environ Health. 1978 4: 173–88.
  • Vorwald AJ, Durkan T, Pratt P. Experi-mental Studies of Asbestosis. Archives of Industrial Hygiene and Occupa-tional Medicine. 1931; 3: 1–28.
  • Charles R. Latham, et al vs. Garlock, Inc. et al. In the District Court Brazoria County, Texas 23rd Judicial District. UnionCarbideCorporation'sResponses to Plaintiffs' First Set of Interrogatories and Requests for Pro-duction, 2001.
  • Worker #360, UCASB07005868.
  • Original death certificate of Paul Whit-lock. 1/3/91.UCASB07006991.
  • Myers JL. Internal correspondence. UCASB07008154-UCASB07008160.
  • Revised death Certificate of Paul Whit-lock. June 14, 1991 (date issued). UCASB07006994.
  • Coroner's amendment to revised death certificate. June 14, 1991 (date issued). UCASB07006995.
  • Cause No. 19785-BH02; Kelly-Moore Paint Company, Inc. v. Dow Chemical Company, et al.; in the 23rd Judicial District Court of Brazoria County. Deposition of John L. Myers taken July 29, 2003.
  • County of Santa Clara Office of the Medical Examiner-Coroner. Report of Autopsy completed by Angelo K. Ozoa, MD, at the Santa Clara County Morgue. January 9, 1991. UCASB07006996-UCASB07007000
  • Lewinsohn HC. A Review of Chest Radiographs of Calidria Corporation Employees on 12/12/84. Full Report: UCASB07100000-UCASB07100329. Specific Reference: UCASB07100009, p. 10.
  • Lewinsohn HC. A Review of Chest Radiographs of Calidria Corporation Employees on 12/12/84. Full Report: UCASB07100000-UCASB07100329. Specific Reference: UCASB07100011, p. 12.
  • Kelly Moore Paint Company, Inc., vs. Dow Chemical Company et al., No. 19785-BH02 Deposition of George Navarro, December 9, 2003.
  • Dow Chemical, The Use of Asbestos as a Thixotrope in Derakane Applica-tions. October 16, 1974.
  • Smith M (Manager of Technical Division, Castor Oil Co.) to J Gallagher, Dupont. July 5, 1972.
  • Asbestos Institute. Conclusive results from a study by international scientists-Quebec chrysotile proven to be far less hazardous. Canada NewsWire: Sept.9, 2003. http://www.finance.lycos.com/qc/riews/story.aspx?syrnbols=ccn:1008cstory=35624326.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.